Bahrain licenses Wegovy for obesity
The Ministry of Health in Bahrain has issued a license for the use of "Wegovy" tablets to treat obesity. It belongs to the GLP-1 medication class, providing an effective oral treatment option for cases of overweight and obesity.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)